Interrogating JAK/STAT signaling in ovarian cancer as a potential oncogenic driver and therapeutic target

被引：0
|
作者：
Rodman, Esther [1 ]
Emch, Michael [1 ]
Bruinsma, Elizabeth [1 ]
Hou, Xiaonan [1 ]
Weroha, John [1 ]
Hawse, John [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1129
引用
收藏
页数：1
相关论文
共 50 条
  • [1] STAT3 signaling in ovarian cancer: a potential therapeutic target
    Liang, Renba
    Chen, Xishan
    Chen, Li
    Wan, Fangzhu
    Chen, Kaihua
    Sun, Yongchu
    Zhu, Xiaodong
    JOURNAL OF CANCER, 2020, 11 (04): : 837 - 848
  • [2] Jak/Stat signaling: A potential target for pancreatic cancer management
    Gong Jingjing
    Batth, Izhar S.
    Kumar, Addanki P.
    CANCER RESEARCH, 2011, 71
  • [3] JAK/STAT as a Potential Therapeutic Target for Osteolytic Diseases
    Godoi, Mariely A.
    Camilli, Angelo C.
    Gonzales, Karen G. A.
    Costa, Vitoria B.
    Papathanasiou, Evangelos
    Leite, Fabio R. M.
    Guimaraes-Stabili, Morgana R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [4] Nitric oxide signaling in human ovarian cancer: A potential therapeutic target
    El-Sehemy, Ahmed
    Postovit, Lynne-Marie
    Fu, YangXin
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2016, 54 : 30 - 37
  • [5] The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma
    Keller, Alexandra
    Wingelhofer, Bettina
    Peter, Barbara
    Bauer, Karin
    Berger, Daniela
    Gamperl, Susanne
    Reifinger, Martin
    Cerny-Reiterer, Sabine
    Moriggl, Richard
    Willmann, Michael
    Valent, Peter
    Hadzijusufovic, Emir
    VETERINARY AND COMPARATIVE ONCOLOGY, 2018, 16 (01) : 55 - 68
  • [6] Interferon-γ-Jak-Stat signaling in pulmonary lymphangioleiomyomatosis and renal anglomyolipoma -: A potential therapeutic target
    El-Hashemite, N
    Kwiatkowski, DJ
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2005, 33 (03) : 227 - 230
  • [7] JAK-STAT signaling as an ARDS therapeutic target: Status and future trends
    Zhang, Yuanteng
    Gao, Zizheng
    Jiang, Feng
    Yan, Hao
    Yang, Bo
    He, Qiaojun
    Luo, Peihua
    Xu, Zhifei
    Yang, Xiaochun
    BIOCHEMICAL PHARMACOLOGY, 2023, 208
  • [8] JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target
    Jiang, Heng
    Yang, Junjie
    Li, Tao
    Wang, Xinyu
    Fan, Zhongcai
    Ye, Qiang
    Du, Yanfei
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [9] EPOR/JAK/STAT Signaling Pathway As Therapeutic Target of Acute Erythroid Leukemia
    Takeda, June
    Yoshida, Kenichi
    Nakagawa, Masahiro Marshall
    Nannya, Yasuhito
    Yoda, Akinori
    Morishita, Daisuke
    Saiki, Ryunosuke
    Chiba, Kenichi
    Tanaka, Hiroko
    Shiraishi, Yuichi
    Kuo, Ming-Chung
    Kerr, Cassandra M.
    Nagata, Yasunobu
    Hiramoto, Nobuhiro
    Hangaishi, Akira
    Nakazawa, Hideyuki
    Ishiyama, Ken
    Miyano, Satoru
    Chiba, Shigeru
    Miyazaki, Yasushi
    Kitano, Toshiyuki
    Usuki, Kensuke
    Sezaki, Nobuo
    Tsurumi, Hisashi
    Miyawaki, Shuichi
    Maciejewski, Jaroslaw P.
    Ishikawa, Takayuki
    Ohyashiki, Kazuma
    Ganser, Arnold
    Heuser, Michael
    Thol, Felicitas
    Shih, Lee-Yung
    Takaori-Kondo, Akifumi
    Makishima, Hideki
    Ogawa, Seishi
    BLOOD, 2021, 138
  • [10] JAK/STAT signaling in cancer
    Heinrich, Peter C.
    Haan, Serge
    Harris, Kevin W.
    Hermanns, Heike M.
    Metz, Silke
    Mueller-Newen, Gerhard
    Schaper, Fred
    Wiesinger, Monique
    BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (08) : 488 - 488
12345